e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Treatment of human pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH)
D. Martolini, P. Onorati, G. Valli, A. M. Ferrazza, P. Marinelli, M. Internullo, L. Sardo, C. Gambardella, B. Pezzuto, C. D. Vizza, P. Palange (Rome, Italy)
Source:
Annual Congress 2011 - Treatment of human pulmonary hypertension
Session:
Treatment of human pulmonary hypertension
Session type:
Thematic Poster Session
Number:
2286
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Martolini, P. Onorati, G. Valli, A. M. Ferrazza, P. Marinelli, M. Internullo, L. Sardo, C. Gambardella, B. Pezzuto, C. D. Vizza, P. Palange (Rome, Italy). Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH). Eur Respir J 2011; 38: Suppl. 55, 2286
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Effects of mean pulmonary arterial pressure and supplemental oxygen on exercise capacity in IPF patients with exercise-induced hypoxemia
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2017
Acute effects of oxygen supplementation during exercise in patients with pulmonary arterial hypertension
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019
Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
The prevalence of ventilatory limitation at peak exercise in pulmonary arterial hypertension
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Effect of dopamine infusion and oxygen supplementation on exercise ventilatory response and endurance in COPD
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Epigenetic effects of exercise and respiratory training in patients with pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Upper extremity aerobic exercise training improves peak oxygen consumption in patients with pulmonary arterial hypertension
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018
Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Tadalafil improves exercise capacity and delays time to clinical worsening in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Year: 2008
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Exercise training in pulmonary hypertension improves muscle efficiency and exercise capacity
Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Year: 2008
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009
ACE-inhibition improves peak exercise oxygen uptake and ventilation in COPD: an effect unrelated to pulmonary function
Source: Eur Respir J 2003; 22: Suppl. 45, 205s
Year: 2003
Influence of exercise training on cardiac baroreflex sensitivity in patients with COPD
Source: Eur Respir J 2004; 23: 396-401
Year: 2004
Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010
Aerobic exercise capacity in COPD patients with and without pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept